Apolipoprotein C Iii | List of Frontiers open access articles

Original Research

Published on 12 Aug 2021

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III

in Pediatric Nephrology

Wei-Ling Chen
You-Lin Tain
Hung-En Chen
Chien-Ning Hsu

Frontiers in Pediatrics

doi 10.3389/fped.2021.706323

4,227 views
12 citations

Original Research

Published on 21 Aug 2024

Association between apolipoprotein C-III levels and coronary calcification detected by intravascular ultrasound in patients who underwent percutaneous coronary intervention

in Lipids in Cardiovascular Disease

Tatsuya Fukase
Tomotaka Dohi
Ryota Nishio
Mitsuhiro Takeuchi
Norihito Takahashi
Yuichi Chikata
Hirohisa Endo
Shinichiro Doi
Hiroki Nishiyama
Iwao Okai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1430203

1,894 views
4 citations

Original Research

Published on 04 Feb 2022

High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin

in Lipids in Cardiovascular Disease

Oliviero Olivieri
Gianni Turcato
Manuel Cappellari
Filippo Stefanoni
Nicola Osti
Francesca Pizzolo
Simonetta Friso
Antonella Bassi
Annalisa Castagna
Nicola Martinelli

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.781383

2,846 views
2 citations

Original Research

Published on 02 Feb 2017

Label-Free Proteome Analysis of Plasma from Patients with Breast Cancer: Stage-Specific Protein Expression

in Cancer Imaging and Image-directed Interventions

Marina Duarte Pinto Lobo
Frederico Bruno Mendes Batista Moreno
Gustavo Henrique Martins Ferreira Souza
Sara Maria Moreira Lima Verde
Renato de Azevedo Moreira
Ana Cristina de Oliveira Monteiro-Moreira

Frontiers in Oncology

doi 10.3389/fonc.2017.00014

7,377 views
38 citations

Original Research

Published on 21 Feb 2022

Plasma Proteome Profiling of Patients With In-stent Restenosis by Tandem Mass Tag-Based Quantitative Proteomics Approach

in Atherosclerosis and Vascular Medicine

Jingyuan Hou
Qiaoting Deng
Sudong Liu
Xiaohong Qiu
Xunwei Deng
Wei Zhong
Zhixiong Zhong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.793405

4,648 views
8 citations

Original Research

Published on 09 May 2022

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus

in Autoimmune and Autoinflammatory Disorders

Juan Carlos Quevedo-Abeledo
Candelaria Martín-González
Carmen Ferrer-Moure
Laura de Armas-Rillo
Maria Vanesa Hernandez-Hernandez
Miguel Á. González-Gay
Iván Ferraz-Amaro

Frontiers in Immunology

doi 10.3389/fimmu.2022.827355

4,165 views
9 citations

Original Research

Published on 26 Aug 2025

HDL from 36-h fasted participants potently promotes efflux of cholesteryl ester from activated microglia

in Neuroinflammation and Neuropathy

Joanne K. Agus
Oscar M. Muñoz Herrera
Christopher H. Rhodes
Jack Jingyuan Zheng
Chenghao Zhu
Maurice Wong
Xinyu Tang
Izumi Maezawa
Lee-Way Jin
Carlito B. Lebrilla

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1629496

2,510 views

Articles

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III

Association between apolipoprotein C-III levels and coronary calcification detected by intravascular ultrasound in patients who underwent percutaneous coronary intervention

High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin

Label-Free Proteome Analysis of Plasma from Patients with Breast Cancer: Stage-Specific Protein Expression

Plasma Proteome Profiling of Patients With In-stent Restenosis by Tandem Mass Tag-Based Quantitative Proteomics Approach

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus

HDL from 36-h fasted participants potently promotes efflux of cholesteryl ester from activated microglia